Interventional Cardiology

Researchers have found a modest increase in risk-adjusted 30-day mortality rates following transcatheter aortic valve replacement (TAVR) between 2019 and 2022.

The CALIPSO trial has unveiled evidence supporting the use of optical coherence tomography in guiding percutaneous coronary intervention for moderate to severe calcified lesions.

A recent randomised open-label trial reveals important findings on the efficacy of optical coherence tomography in guiding angioplasty for left main coronary artery lesions.

The NOTION-2 trial is a pivotal study that focused on low surgical risk patients aged 75 years or younger, including both tricuspid and bicuspid aortic stenosis (AS) cases…

Results of the REC-CAGEFREE II trial were presented today at EuroPCR by Ling Tao, FAHA Xijing hospital, Xi’an, China on behalf all REC-CAGEFREE II investigators….

The Transcatheter Valve and Vessels (TCW) Trial, the first dedicated randomised, international study in patients with both aortic stenosis and advanced coronary disease, has delivered new insights…

A groundbreaking study, the AID-ANGIO, has revolutionised the diagnostic approach to chronic coronary syndromes…

Cerebral embolism protection can improve survival and reduce the severity of procedure-related strokes in patients who have had transcatheter aortic valve replacement…